These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37985399)

  • 1. Microglial immunometabolism endophenotypes contribute to sex difference in Alzheimer's disease.
    Hou Y; Caldwell JZK; Lathia JD; Leverenz JB; Pieper AA; Cummings J; Cheng F
    Alzheimers Dement; 2024 Feb; 20(2):1334-1349. PubMed ID: 37985399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial senescence contributes to female-biased neuroinflammation in the aging mouse hippocampus: implications for Alzheimer's disease.
    Ocañas SR; Pham KD; Cox JEJ; Keck AW; Ko S; Ampadu FA; Porter HL; Ansere VA; Kulpa A; Kellogg CM; Machalinski AH; Thomas MA; Wright Z; Chucair-Elliott AJ; Freeman WM
    J Neuroinflammation; 2023 Aug; 20(1):188. PubMed ID: 37587511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
    Counts SE; Che S; Ginsberg SD; Mufson EJ
    J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in Alzheimer's may be associated with TLR4-LYN expression in damage associated microglia and neuronal phagocytosis.
    Islam R; Rajan R; Choudhary H; Vrionis F; Hanafy KA
    J Cell Physiol; 2024 Jun; 239(6):e30916. PubMed ID: 36409648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.
    Jin JJ; Kim HD; Maxwell JA; Li L; Fukuchi K
    J Neuroinflammation; 2008 May; 5():23. PubMed ID: 18510752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease.
    Galea E; Weinstock LD; Larramona-Arcas R; Pybus AF; Giménez-Llort L; Escartin C; Wood LB
    Neurobiol Dis; 2022 May; 166():105655. PubMed ID: 35143967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial Immunometabolism in Alzheimer's Disease.
    Shippy DC; Ulland TK
    Front Cell Neurosci; 2020; 14():563446. PubMed ID: 33192310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex specific molecular networks and key drivers of Alzheimer's disease.
    Guo L; Cao J; Hou J; Li Y; Huang M; Zhu L; Zhang L; Lee Y; Duarte ML; Zhou X; Wang M; Liu CC; Martens Y; Chao M; Goate A; Bu G; Haroutunian V; Cai D; Zhang B
    Mol Neurodegener; 2023 Jun; 18(1):39. PubMed ID: 37340466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial efferocytosis: Diving into the Alzheimer's disease gene pool.
    Romero-Molina C; Garretti F; Andrews SJ; Marcora E; Goate AM
    Neuron; 2022 Nov; 110(21):3513-3533. PubMed ID: 36327897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental toxicant exposure in a mouse model of Alzheimer's disease induces differential sex-associated microglial activation and increased susceptibility to amyloid accumulation.
    vonderEmbse AN; Hu Q; DeWitt JC
    J Dev Orig Health Dis; 2017 Aug; 8(4):493-501. PubMed ID: 28460650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5×FAD mice.
    Xue F; Tian J; Yu C; Du H; Guo L
    Neurobiol Dis; 2021 May; 152():105272. PubMed ID: 33540048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain.
    Felsky D; Patrick E; Schneider JA; Mostafavi S; Gaiteri C; Patsopoulos N; Bennett DA; De Jager PL
    Mol Neurodegener; 2018 Jul; 13(1):38. PubMed ID: 30041668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial immunophenotype in dementia with Alzheimer's pathology.
    Minett T; Classey J; Matthews FE; Fahrenhold M; Taga M; Brayne C; Ince PG; Nicoll JA; Boche D;
    J Neuroinflammation; 2016 Jun; 13(1):135. PubMed ID: 27256292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
    Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
    Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner.
    Wong MY; Lewis M; Doherty JJ; Shi Y; Cashikar AG; Amelianchik A; Tymchuk S; Sullivan PM; Qian M; Covey DF; Petsko GA; Holtzman DM; Paul SM; Luo W
    J Neuroinflammation; 2020 Jun; 17(1):192. PubMed ID: 32552741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.